Repurposing of FDA-approved drugs as novel radiosensitisers in hypoxic prostate cancer.
Name:
PIIS0167814018306923.pdf
Size:
556.8Kb
Format:
PDF
Description:
Full text, Open Access article
Authors
Bibby, BThiruthaneeswaran, N
Yang, Lingjian
McArt, D
O'Reilly, P
Roberts, D
Choudhury, Ananya
West, Catharine M L
Affiliation
University of Manchester, Division of Cancer Sciences, ManchesterIssue Date
2018